WPC-952

GPTKB entity

Properties (47)
Predicate Object
gptkbp:instanceOf chemical compound
gptkbp:application potential pharmaceutical agent
gptkbp:built synthesis complexity
gptkbp:campusFacilities various universities
gptkbp:chemicalFormula thiazole derivatives
contains thiazole rings
C12H14N2O4S
gptkbp:clinicalTrials under investigation
gptkbp:collaborations pharmaceutical companies
gptkbp:colors white to off-white powder
gptkbp:compatibleWith inhibitor of certain enzymes
gptkbp:composedOf via thiazole derivatives
gptkbp:dissolved soluble in DMSO
gptkbp:distribution 1.25 g/cm³
gptkbp:drugInterdiction moderate absorption
gptkbp:endOfLife 4 hours
gptkbp:environmentalImpact low toxicity in vitro
gptkbp:financial_aid stable under normal conditions
gptkbp:funding grants from government agencies
gptkbp:future_plans clinical trials and development
https://www.w3.org/2000/01/rdf-schema#label WPC-952
gptkbp:iceClass 150-155 °C
not determined
gptkbp:impact none reported in studies
gptkbp:is_aimed_at cancer
gptkbp:isATypeOf 123456-78-9
gptkbp:judgingCriteria HPLC
gptkbp:market not commercially available
gptkbp:nutritionalValue liver metabolism
gptkbp:origin N-(4-(2-(4-(dimethylamino)phenyl)thiazol-4-yl)thiazol-2-yl)phenyl)acetamide
gptkbp:patentCitation protected by patents
gptkbp:patentStatus patented
gptkbp:publications multiple peer-reviewed articles
gptkbp:regulatoryCompliance not approved for clinical use
gptkbp:related_to thiazole derivatives
gptkbp:releaseYear 2010
gptkbp:research_areas medicinal chemistry
gptkbp:route multi-step synthesis
gptkbp:safety handle with care
gptkbp:safetyFeatures available
gptkbp:storage store in a cool, dry place
gptkbp:team 2.5
gptkbp:triggerType enzyme inhibition
gptkbp:trimLevels neutral
gptkbp:uses research chemical
gptkbp:waterManagement urinary excretion
gptkbp:weight 278.32 g/mol